Stay informed with the latest updates for the inheritable blood disorders community.

Medical Advisory
Medical Advisory
Medical Advisory # 429: Notice Regarding BAXJECT® II Reconstitution Devices…
Press Releases
new NBDF
The National Hemophilia Foundation is Now the National Bleeding…
NBDF & Community
Patient Assistance Programs
HANDI Team Reminder – Learn More About Patient Assistance Programs
Peer-Reviewed Journal Summaries
Gynecologists Have Significant Part to Play in Shrinking Diagnostic Gaps
Advocacy & Legislative
Government Relations Update - April 2023
Government Relations Update - July 2023
Press Releases
We look forward to seeing you at NHF's Bleeding Disorders Conference 2023.
Embracing Change and Empowering Communities: 2023 Bleeding Disorders…
Peer-Reviewed Journal Summaries
Patient Safety in the Age of Gene Therapy a Central Focus of Review…
NBDF & Community
Paving the Road Ahead
Medical
Birth control pills
FDA Approves First-Ever Nonprescription Oral Contraceptive
NBDF & Community
Peggy, a longtime community member shares her family's history of involvement and advocacy.
A Longtime Legacy
Advocacy & Legislative
Government Relations Update - April 2023
Government Relations Update - June 2023
Industry
Clinical Trial Lab Research
New Trial Data Shows ALTUVIIIO™ Prophylaxis Effective in Children
Industry
FDA Approval
Hemophilia A Gene Therapy Product Receives U.S. FDA Approval
Medical
Doctor and patient
Patient-Clinician Partnerships the Theme of ASCO Presidential Address
Industry
First Hemophilia B Patient Dosed with Gene Therapy Product